Welcome KIM GROUP

Cycle of ADP-ribosylation and PARP inhibitor efficacy in cancer treatment

The main goal of our Laboratory is to understand the mechanism and function of the cycle of ADP-ribosylation and to leverage this new information to develop novel tumor-selective therapeutics to enhance PARP inhibitor efficacy in cancer treatment.